Recent Advances on High-Efficiency of Micrornas in Different Types of Lung Cancer: A Comprehensive Review Publisher



Sadeghi MS¹ ; Lotfi M² ; Soltani N³ ; Farmani E⁴ ; Fernandez JHO⁵ ; Akhlaghitehrani S⁶ ; Mohammed SH⁷ ; Yasamineh S⁸ ; Kalajahi HG⁹ ; Gholizadeh O⁸
Source: Cancer Cell International Published:2023

Abstract

Carcinoma of the lung is among the most common types of cancer globally. Concerning its histology, it is categorized as a non-small cell carcinoma (NSCLC) and a small cell cancer (SCLC) subtype. MicroRNAs (miRNAs) are a member of non-coding RNA whose nucleotides range from 19 to 25. They are known to be critical regulators of cancer via epigenetic control of oncogenes expression and by regulating tumor suppressor genes. miRNAs have an essential function in a tumorous microenvironment via modulating cancer cell growth, metastasis, angiogenesis, metabolism, and apoptosis. Moreover, a wide range of information produced via several investigations indicates their tumor-suppressing, oncogenic, diagnostic assessment, and predictive marker functions in different types of lung malignancy. miRNA mimics or anti-miRNAs can be transferred into a lung cancer cell, with possible curative implications. As a result, miRNAs hold promise as targets for lung cancer treatment and detection. In this study, we investigate the different functions of various miRNAs in different types of lung malignancy, which have been achieved in recent years that show the lung cancer-associated regulation of miRNAs expression, concerning their function in lung cancer beginning, development, and resistance to chemotherapy, also the probability to utilize miRNAs as predictive biomarkers for therapy reaction. Graphical abstract: [Figure not available: see fulltext.] © 2023, The Author(s).